Modular platforms
Ypsomed’s self-injection products are modular platforms built for speed, reliability, and scale. Developed and validated in advance, each platform offers a proven starting point that accelerates development and reduces customer project risk, scalable from early clinical trials through to commercial launch.
Industrialized and ready
Our platforms are fully developed and tested, with validated designs, pre-qualified components, and supported by an established industrial manufacturing infrastructure. This provides customers with a proven foundation, saving months on the timeline and moving faster to market.
Designed for Versatility
Ypsomed platforms are engineered to support a wide range of drug formulations across a broad spectrum of viscosities and fill volumes. This flexibility is built into the platform architecture, enabling customization without changing the core device design.
Pen injectors
Autoinjectors
Wearable injectors
Digital health
Regulatory-ready
Each platform is built to support a smooth regulatory pathway. We provide detailed technical documentation and device-specific data for use in customer submissions. Early-stage usability testing data not only guides iterative platform design and modification, but also provides valuable data for future customers as a basis for their own usability testing.
Patient-centric and eco-designed
Usability and patient adherence are at the core of every platform, with a focus on creating patented, patient-focused technologies that are intuitive and easy to use. Each platform undergoes formative usability testing with representative user groups, providing insight that shapes development and offers valuable data to support future human factors work. Since 2021, our newly developed platforms adhere to eco-design principles, verified as part of our ISO 14001-certified sustainability program.
